Literature DB >> 568748

The pathophysiology of demyelination and its implications for the symptomatic treatment of multiple sclerosis.

T A Sears, H Bostock, M Sheratt.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 568748     DOI: 10.1212/wnl.28.9_part_2.21

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Evoked potential (EP) alterations in experimental allergic encephalomyelitis (EAE): early delays and latency reductions without plaques.

Authors:  D Gambi; T Fulgente; D Melchionda; M Onofrj
Journal:  Ital J Neurol Sci       Date:  1996-02

2.  Low density of sodium channels supports action potential conduction in axons of neonatal rat optic nerve.

Authors:  S G Waxman; J A Black; J D Kocsis; J M Ritchie
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat.

Authors:  D A Utzschneider; D R Archer; J D Kocsis; S G Waxman; I D Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

4.  The spatial distribution of excitability and membrane current in normal and demyelinated mammalian nerve fibres.

Authors:  H Bostock; T A Sears; R M Sherratt
Journal:  J Physiol       Date:  1983-08       Impact factor: 5.182

Review 5.  The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.

Authors:  K J Smith; W I McDonald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

6.  The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres.

Authors:  H Bostock; T A Sears; R M Sherratt
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

7.  Multiple sclerosis: failure of treatment with verapamil in a pilot trial.

Authors:  S Komoly; G Jakab; A Fazekas
Journal:  J Neurol       Date:  1986-02       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.